Bis-Tyrphostin

A protein tyrosine kinase inhibitor that competitively inhibits epidermal growth factor receptor kinase activity. (NCI)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2015
0119952015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The use of 3-dimensional (3D) collagen gels has yielded new insights into the migratory behaviour of cancer cells. While the… (More)
Is this relevant?
2011
2011
Cerebellar development in the postnatal period is mainly characterized by an intense cellular proliferation in the external… (More)
Is this relevant?
2010
2010
INTRODUCTION The devasting effect of cancer and treatment thereof contribute to sexual dysfunction. Recently, a series of… (More)
Is this relevant?
2009
2009
Probing the dynamin binding site: Bis-tyrphostin (1, Bis-T), is a potent inhibitor of the phospholipid-stimulated GTPase activity… (More)
Is this relevant?
2005
2005
Platelet-activating factor (PAF), a potent inflammatory mediator, is involved in endothelial permeability. This study was… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1995
1995
1. A pharmacological characterization of tyrosine kinase inhibitors (TKI) belonging to two distinct groups (competitors at the… (More)
Is this relevant?